Research Progress of Long Non-Coding RNA in Hematological Tumors --Review / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 306-310, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-971142
ABSTRACT
Long non-coding RNA (lncRNA) is a hot topic in the field of researching tumor pathogenesis, and the importance in hematologic malignancies has been gradually being elucidated. LncRNA not only regulates hematological tumorigenesis and progression through affecting various biological processes such as cell proliferation, differentiation, pluripotency and apoptosis; moreover, abnormal expression and mutation of lncRNA are closely related to drug resistance and prognosis. Thus lncRNA can be used as novel biomarker and potential therapeutic target for hematological tumors. In this review, we will focus on the latest progress of lncRNA in hematological tumors to provide new ideas for the clinical diagnosis, prognostic evaluation together with research and development of target drugs for hematologic malignancies.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Regulación Neoplásica de la Expresión Génica
/
Transformación Celular Neoplásica
/
Neoplasias Hematológicas
/
ARN Largo no Codificante
/
Carcinogénesis
/
Neoplasias
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Experimental Hematology
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS